Informatie:
Fout:
ID
37633
Beschrijving
Anti-inflammatory Effects of Rivaroxaban Versus Dabigatran; ODM derived from: https://clinicaltrials.gov/show/NCT02331602
Link
https://clinicaltrials.gov/show/NCT02331602
Trefwoorden
Versies (1)
- 12-08-19 12-08-19 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
12 augustus 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Atrial Fibrillation NCT02331602
Eligibility Atrial Fibrillation NCT02331602
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT02331602
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Atrial Fibrillation
Item
non-valvular atrial fibrillation
boolean
C0004238 (UMLS CUI [1])
CHA2DS2-VASc score
Item
a chads2-vasc score of 1 or more
boolean
C4049268 (UMLS CUI [1])
Medical contraindication Rivaroxaban | Medical contraindication Dabigatran
Item
contraindication for rivaroxaban or dabigatran
boolean
C1301624 (UMLS CUI [1,1])
C1739768 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C2348066 (UMLS CUI [2,2])
C1739768 (UMLS CUI [1,2])
C1301624 (UMLS CUI [2,1])
C2348066 (UMLS CUI [2,2])
Cerebrovascular accident | EMBOLISM, SYSTEMIC ARTERIAL | Acute Coronary Syndrome | Peripheral Arterial Disease
Item
stroke or systemic embolism, acute coronary syndromes or peripheral artery disease within 6 months before enrollment
boolean
C0038454 (UMLS CUI [1])
C0149876 (UMLS CUI [2])
C0948089 (UMLS CUI [3])
C1704436 (UMLS CUI [4])
C0149876 (UMLS CUI [2])
C0948089 (UMLS CUI [3])
C1704436 (UMLS CUI [4])
Heart failure
Item
acute heart failure
boolean
C0018801 (UMLS CUI [1])
Chronic Kidney Failure Severe | Creatinine clearance measurement
Item
severe chronic renal failure (creatinine clearance < 30ml/min.)
boolean
C0022661 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0205082 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
Antiplatelet therapy Dual
Item
receiving dual antiplatelet therapy
boolean
C1096021 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C0205173 (UMLS CUI [1,2])
Body Weight
Item
patients with a body weight of 50kg or less
boolean
C0005910 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension
boolean
C1868885 (UMLS CUI [1])
Malignant Neoplasms | Collagen Disease | Communicable Disease
Item
active malignancy, collagen disease, or infectious disease
boolean
C0006826 (UMLS CUI [1])
C0009326 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
C0009326 (UMLS CUI [2])
C0009450 (UMLS CUI [3])
Operative Surgical Procedure
Item
patients undergoing surgery within 6 months before enrollment
boolean
C0543467 (UMLS CUI [1])
Catheter ablation for atrial fibrillation Planned
Item
patients who are planned to undergoing catheter ablation for atrial fibrillation
boolean
C2702800 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,2])
Study Subject Participation Status Rejected Physician Decision
Item
patients who are not allowed to participate in the trial by judgement of the treating physician
boolean
C2348568 (UMLS CUI [1,1])
C1548437 (UMLS CUI [1,2])
C1709536 (UMLS CUI [1,3])
C1548437 (UMLS CUI [1,2])
C1709536 (UMLS CUI [1,3])